How many insider declarations has Levy Adam D. filed?

Levy Adam D. has filed 3 public insider declarations with SEC (Form 4).

What is Levy Adam D.'s role?

Levy Adam D.'s reported role is not specified by the regulator across the filings.

Which companies does Levy Adam D. report trades for?

Levy Adam D. reports trades for Acrivon Therapeutics, Inc..

What is Levy Adam D.'s declared buy vs sell volume?

Across the available history, declared buys total 13k€ and disposals 2k€.

← Executives ★ Sign in to follow

LA

Levy Adam D.

CFO

·SEC (Form 4)

Acrivon Therapeutics, Inc.

累计流向

0

申报总数

0

公司

€12,883

▲ 买入（1 笔）

€1,557

▼ 卖出（1 笔）

内部人交易记录

其他

已披露买入

1

已披露卖出

1

T+90 胜率

0%

T+90 平均收益

-6.8%

基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。

信号历史

Discover the full record of transactions filed by Levy Adam D.. Director active across 1 company, notably Acrivon Therapeutics, Inc.. Aggregated, 3 reports have been logged. Breakdown: 1 buy · 1 sell. Total volume traded: €14k. History available since 1 August 2025. The latest transaction was filed on 4 August 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.

Companies and markets linked to Levy Adam D.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Acrivon Therapeutics, Inc. (US)

申报3 总计

▼

Levy Adam D.

Chief Financial Officer高管2026年8月4日Acrivon Therapeutics, Inc.

US$1,7930SEC ↗

1,142 股@ US$1.57Common StockSEC:0000905148-26-003499:0

▲

Levy Adam D.

Chief Financial Officer高管2026年1月14日Acrivon Therapeutics, Inc.

US$14,99946SEC ↗

8,832 股@ US$1.698390.9% 占其流量Common StockSEC:0000905148-26-000225:0

标准退出：2026年4月14日 (T+90)

●

Levy Adam D.

Chief Financial Officer高管2025年8月1日Acrivon Therapeutics, Inc.

US$1,46727SEC ↗

1,164 股@ US$1.26100.0% 占其流量Common StockSEC:0000905148-25-002732:0

3 条申报中的 3 条

InsidersTradesSigma

← Executives ★ Sign in to follow

LA

Levy Adam D.

CFO

·SEC (Form 4)

Acrivon Therapeutics, Inc.

累计流向

0

申报总数

0

公司

€12,883

▲ 买入（1 笔）

€1,557

▼ 卖出（1 笔）

内部人交易记录

其他

已披露买入

1

已披露卖出

1

T+90 胜率

0%

T+90 平均收益

-6.8%

基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。

信号历史

Discover the full record of transactions filed by Levy Adam D.. Director active across 1 company, notably Acrivon Therapeutics, Inc.. Aggregated, 3 reports have been logged. Breakdown: 1 buy · 1 sell. Total volume traded: €14k. History available since 1 August 2025. The latest transaction was filed on 4 August 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.

Companies and markets linked to Levy Adam D.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Acrivon Therapeutics, Inc. (US)

申报3 总计

▼

Levy Adam D.

Chief Financial Officer高管2026年8月4日Acrivon Therapeutics, Inc.

US$1,7930SEC ↗

1,142 股@ US$1.57Common StockSEC:0000905148-26-003499:0

▲

Levy Adam D.

Chief Financial Officer高管2026年1月14日Acrivon Therapeutics, Inc.

US$14,99946SEC ↗

8,832 股@ US$1.698390.9% 占其流量Common StockSEC:0000905148-26-000225:0

标准退出：2026年4月14日 (T+90)

●

Levy Adam D.

Chief Financial Officer高管2025年8月1日Acrivon Therapeutics, Inc.

US$1,46727SEC ↗

1,164 股@ US$1.26100.0% 占其流量Common StockSEC:0000905148-25-002732:0

3 条申报中的 3 条

Levy Adam D.

内部人交易记录

Companies and markets linked to Levy Adam D.

Related entities

Levy Adam D.

内部人交易记录

Companies and markets linked to Levy Adam D.

Related entities